- Home
- CSGP vs ICLR Comparison
CSGP vs ICLR Comparison
Compare CSGP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGP
- ICLR
- Stock Information
- Founded
- CSGP 1987
- ICLR 1990
- Country
- CSGP United States
- ICLR Ireland
- Employees
- CSGP N/A
- ICLR N/A
- Industry
- CSGP Business Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CSGP Consumer Discretionary
- ICLR Health Care
- Exchange
- CSGP Nasdaq
- ICLR Nasdaq
- Market Cap
- CSGP 31.9B
- ICLR 26.3B
- IPO Year
- CSGP 1998
- ICLR 1998
- Fundamental
- Price
- CSGP $77.45
- ICLR $302.52
- Analyst Decision
- CSGP Strong Buy
- ICLR Strong Buy
- Analyst Count
- CSGP 14
- ICLR 9
- Target Price
- CSGP $96.14
- ICLR $352.56
- AVG Volume (30 Days)
- CSGP 1.7M
- ICLR 296.1K
- Earning Date
- CSGP 10-22-2024
- ICLR 10-23-2024
- Dividend Yield
- CSGP N/A
- ICLR N/A
- EPS Growth
- CSGP N/A
- ICLR 39.27
- EPS
- CSGP 0.52
- ICLR 8.61
- Revenue
- CSGP $2,598,900,000.00
- ICLR $8,331,892,000.00
- Revenue This Year
- CSGP $14.05
- ICLR $6.84
- Revenue Next Year
- CSGP $14.46
- ICLR $8.14
- P/E Ratio
- CSGP $148.94
- ICLR $35.15
- Revenue Growth
- CSGP 11.99
- ICLR 5.42
- 52 Week Low
- CSGP $67.35
- ICLR $221.20
- 52 Week High
- CSGP $100.38
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- CSGP 57.26
- ICLR 33.57
- Support Level
- CSGP $75.33
- ICLR $317.11
- Resistance Level
- CSGP $78.07
- ICLR $323.25
- Average True Range (ATR)
- CSGP 1.47
- ICLR 7.12
- MACD
- CSGP 0.20
- ICLR -1.81
- Stochastic Oscillator
- CSGP 67.19
- ICLR 7.52
About CSGP CoStar Group Inc.
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.